CliffBio
small molecule

SIGNIFOR

PASIREOTIDE DIASPARTATE

Loss of exclusivityDecember 2026latest FDA-listed patent expiry
CompanyRecordati Rare Diseases Inc. →View the full company profile on CliffBio

Drug detail

Brand nameSIGNIFOR
Active ingredientPASIREOTIDE DIASPARTATE
StrengthEQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)
Dosage formSOLUTION
RouteSUBCUTANEOUS
ModalitySmall molecule
FDA approvalDecember 2012
Marketing statusRX

Listed patents

PatentExpiresType
7473761December 2026substance, product

More from Recordati Rare Diseases Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SIGNIFOR patent cliff — loss of exclusivity December 2026 | CliffBio